| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $97K | -52.6% |
| SG&A Expense | $391K | -46.7% |
| Interest Expense | $42K | — |
| Net Income | -$530K | +43.5% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $100K | +32.5% |
| Current Assets | $160K | +60.6% |
| Total Assets | $302K | +142.5% |
| Current Liabilities | $65K | +79.2% |
| Total Liabilities | $566K | +1229.9% |
| Stockholders' Equity | -$265K | -423.5% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$408K | +36.8% |
| Investing Cash Flow | $480K | -7.5% |
| Financing Cash Flow | -$48K | -109.2% |